Âé¶¹¹ÙÍø

Kontakt

Halogenated Rocaglate Derivatives

Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses

verfasst von
Catherine Victoria, Göran Schulz, Mara Klöhn, Saskia Weber, Cora M. Holicki, Yannick Brüggemann, Miriam Becker, Gisa Gerold, Martin Eiden, Martin H. Groschup, Eike Steinmann, Andreas Kirschning
Abstract

The synthesis of a library of halogenated rocaglate derivatives belonging to the flavagline class of natural products, of which silvestrol is the most prominent example, is reported. Their antiviral activity and cytotoxicity profile against a wide range of pathogenic viruses, including hepatitis E, Chikungunya, Rift Valley Fever virus and SARS-CoV-2, were determined. The incorporation of halogen substituents at positions 4′, 6 and 8 was shown to have a significant effect on the antiviral activity of rocaglates, some of which even showed enhanced activity compared to CR-31-B and silvestrol.

Organisationseinheit(en)
Institut für Organische Chemie
Externe Organisation(en)
Ruhr-±«²Ô¾±±¹±ð°ù²õ¾±³Ùä³Ù Bochum
Stiftung Tierärztliche Hochschule Hannover
±«²Ô¾±±¹±ð°ù²õ¾±³Ùä³Ù UmeÃ¥
Friedrich-Loeffler-Institut (FLI)
Typ
Artikel
Journal
Journal of medicinal chemistry
Band
67
Seiten
289-321
Anzahl der Seiten
33
ISSN
0022-2623
Publikationsdatum
11.01.2024
Publikationsstatus
³Õ±ð°ùö´Ú´Ú±ð²Ô³Ù±ô¾±³¦³ó³Ù
Peer-reviewed
Ja
ASJC Scopus Sachgebiete
Molekularmedizin, Wirkstoffforschung
Ziele für nachhaltige Entwicklung
SDG 3 – Gute Gesundheit und Wohlergehen
Elektronische Version(en)
(Zugang: Offen)